Company: BKYI
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001437749-25-016136
Chunk: 17

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-05-12
Form: 424B3
Chunk 17
---
center'>10</div>

Transfer Agent and Registrar. The transfer agent and registrar for our common stock is Broadridge Corporate Issuer Solutions, Inc.

Preferred Stock

The following summary description of our preferred stock is based on the provisions of our certificate of incorporation and bylaws, which are incorporated by reference into the registration statement which includes this prospectus, and the applicable provisions of the DGCL. This information may not be complete in all respects and is qualified in its entirety by reference to the provisions of our certificate of incorporation, bylaws and the DGCL. For information on how to obtain copies of our certificate of incorporation and bylaws, see the information below under the heading “Where You Can Find Additional Information.”

General. We currently have authority to issue up to 5,000,000 shares of preferred stock, $0.0001 par value per share, none of which are outstanding. We may amend from time to time our certificate of incorporation to increase the number of authorized shares of preferred stock or to designate a new series of preferred stock. Unless required by law, the authorized shares of preferred stock will be available for issuance without further action by you. Our Board of Directors is able to determine, with respect to any series of preferred stock, the powers (including voting powers), preferences and relative, participating, optional or other special rights, and the qualifications, limitations or restrictions thereof, including, without limitation:

| ● | the designation of the series;                                                                                                                                                                                                                                                                                                                                                                                                                             |
| ● | the number of shares of the series, which our Board of Directors may, except where otherwise provided in the preferred stock designation, increase (but not above the total number of authorized shares of the class) or decrease (but not below the number of shares then outstanding);                                                                                                                                                                   |
| ● | whether dividends, if any, will be cumulative or non-cumulative and the dividend rate of the series;                                                                                                                                                                                                                                                                                                                                                       |
| ● | the dates at which dividends, if any, will be payable;                                                                                                                                                                                                                                                                                                                                                                                                     |
| ● | the redemption rights and price or prices, if any, for shares of the series;                                                                                                                                                                                                                                                                                                                                                                               |
| ● | the terms and amounts of any sinking fund provided for the purchase or redemption of shares of the series;                                                                                                                                                                                                                                                                                                                                                 |
| ● | the amounts payable on shares of the series in the event of any voluntary or involuntary liquidation, dissolution or winding-up of our affairs;                                                                                                                                                                                                                                                                                                            |
| ● | whether the shares of the series will be convertible into shares of any other class